Bliss GVS Pharma Ltd
Next 500 2022
+ 4 More
+ 4 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#456(2022)#390(2021)#339(2020)#329(2019)#366(2018)
#456(2022)#390(2021)#339(2020)#329(2019)#366(2018)
Financial Data 2024
Revenue
807
(INR Cr)
Net Operating Income
770
(INR Cr)
Assets
1,105
(INR Cr)
Profit
75
(INR Cr)
Net Worth
967
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 807 8.7% | 742 -8.1% | 808 32.6% | 609 -15.9% | 724 -23.2% | 943 12.0% | 842 2.6% | 821 42.6% | 575 35.8% | 424 13.6% | 373 -10.5% | 417 47.2% | 283 28.0% | 221 28.8% | 172 23.1% | 140 - |
| Net Operating Income (INR Cr) | 770 2.48% | 752 0.55% | 747 29.49% | 577 -16.26% | 689 -23.29% | 899 10.30% | 815 2.03% | 798 45.99% | 547 34.33% | 407 18.13% | 345 -13.11% | 397 48.73% | 267 21.86% | 219 0.00% | 169 27.03% | 133 29.85% |
| Profit (INR Cr) | 75 6.5% | 71 371.1% | 15 -78.0% | 68 -29.6% | 97 -21.4% | 124 110.4% | 59 -28.4% | 82 -0.5% | 82 37.7% | 60 46.2% | 41 -29.0% | 58 9.9% | 53 29.3% | 41 -2.6% | 42 11.4% | 37 - |
| Assets (INR Cr) | 1105 8.2% | 1022 6.8% | 957 0.5% | 952 8.3% | 879 15.1% | 764 14.4% | 668 -14.5% | 780 34.8% | 579 12.9% | 513 9.0% | 471 12.1% | 420 63.9% | 256 46.1% | 175 24.6% | 141 40.9% | 100 - |
| Net Worth (INR Cr) | 967 9.4% | 884 8.0% | 819 1.3% | 808 9.9% | 736 13.9% | 646 20.5% | 536 10.2% | 487 17.9% | 413 22.4% | 337 17.5% | 287 11.2% | 258 22.5% | 211 26.4% | 167 0.0% | 133 36.6% | 98 57.6% |
| Employee Cost (INR Cr) | 96 10.9% | 86 13.2% | 76 11.8% | 68 26.8% | 54 26.9% | 42 -38.9% | 69 12.8% | 61 81.8% | 34 14.6% | 29 25.5% | 23 55.6% | 15 146.0% | 6 42.2% | 4 65.8% | 3 22.6% | 2 - |
| Interest Cost (INR Cr) | 7 | 10 | 5 | 6 | 8 | 4 | 23 | 20 | 19 | 16 | 18 | 10 | 4 | 2 | 2 | 2 |
| Cash & Bank Balance (INR Cr) | 216 | 103 | 178 | 145 | 103 | 107 | 89 | 151 | 78 | 57 | 80 | 50 | 58 | 18 | 15 | 7 |
| Total Debt (INR Cr) | 100 | 102 | 109 | 122 | 126 | 102 | 118 | 225 | 132 | 160 | 173 | 148 | 45 | 8 | 8 | 2 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 9.4% | 9.5% | 1.9% | 11.2% | 13.4% | 13.1% | 7.0% | 10.0% | 14.3% | 14.1% | 11.0% | 13.8% | 18.6% | 18.4% | 24.3% | 26.8% |
| Profit As % Of Assets | 6.8% | 6.9% | 1.6% | 7.2% | 11.1% | 16.2% | 8.8% | 10.5% | 14.2% | 11.7% | 8.7% | 13.7% | 20.5% | 23.2% | 29.6% | 37.5% |
| Profit As % Of Networth | 7.8% | 8.0% | 1.8% | 8.5% | 13.2% | 19.2% | 11.0% | 16.9% | 20.0% | 17.8% | 14.3% | 22.4% | 24.9% | 24.4% | 31.3% | 38.4% |
| Interest Cost to EBITDA % | 5.7% | 8.8% | 10.6% | 5.2% | 6.9% | 2.8% | 14.0% | 9.7% | 12.0% | 15.9% | 25.3% | 8.7% | 5.7% | 3.7% | 4.0% | 5.8% |
| Debt to Equity Ratio | 0.10 | 0.12 | 0.13 | 0.15 | 0.17 | 0.16 | 0.22 | 0.46 | 0.32 | 0.47 | 0.60 | 0.57 | 0.21 | 0.05 | 0.06 | 0.02 |
| RONW | 11.0% | 9.0% | 5.4% | 9.6% | 13.8% | 21.4% | 20.9% | 25.1% | 26.7% | 19.7% | 14.7% | 24.7% | 27.9% | 24.4% | 36.2% | 47.0% |
| ROCE | 14.8% | 12.1% | 14.2% | 12.2% | 16.9% | 26.5% | 29.0% | 31.0% | 32.0% | 23.5% | 20.1% | 35.3% | 38.7% | 31.4% | 39.7% | 51.4% |